Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDER’s 50 Open Leadership Posts Could Be Bigger Hiring Challenges After Trump Freeze

Executive Summary

President Trump’s hiring freeze on civilian employees will exacerbate the Center for Drugs Evaluation & Research’s existing difficulties in recruiting and retaining qualified individuals. CDER is currently 591 positions under the hiring ceiling, include 50 open positions within CDER management.

You may also be interested in...



US FDA Still Waiting For Cures Money, Woodcock Says

When asked about Cures-related hiring, CDER Director says to her knowledge, no funding has been received yet.

US FDA Faces Hiring Slowdown, Funding Cuts In Trump's FY 17 Plan

Suggested cuts to appropriations bill funding government for remainder of fiscal year 2017 also includes 'administrative savings.'

The Freeze Thaws: US FDA Allowed To Hire Staff For Cures, User Fee Activity

White House allowed agency to hire some new employees, but lawmakers remain concerned about federal hiring freeze's effect on FDA.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS119968

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel